Nantradol
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171845This classification denotes an analgesic agent with the molecular formula C27H35NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9KB5WI7MQ6, chemically known as 1,9-phenanthridinediol, 5,6,6a,7,8,9,10, 10a-octahydro-6-methyl-3-(1-methyl-4-phenylbutoxy)-, 1-acetate, hydrochloride, (6a,6a.alpha.,9.alpha.,10a.beta.)- but generally known as nantradol, which bears US NIH Compound Identifier 107822. European Medicines Agency schedules Nantradol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09151MIG. The term NANTRADOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). NANTRADOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nantradol under HS 29339990 and SITC 51577. As of Q4 2014, NANTRADOL remains the US FDA Preferred Term for this commodity. Nantradol bears US NLM identifiers UMLS ID C0068401 and NCI Concept Code C83983. SMILES: OC1CC2C(CC1)C(NC1C2C(OC(=O)C)CC(OC(CCCC2CCCCC2)C)C1)C.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.